Karyopharm Therapeutics (KPTI) Shares Outstanding (Entity) (2012 - 2026)
Karyopharm Therapeutics (KPTI) recorded Shares Outstanding (Entity) of 28.94 million in Q2 2026, up 234.7% from 8.65 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends
For FY2025, Karyopharm Therapeutics reported Shares Outstanding (Entity) of 10.94 million, up 30.0% from FY2024.
- Annual Shares Outstanding (Entity) has increased for 14 straight years, with a five-year compound annual growth rate of 17.3% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Entity) came in at 8.41 million in FY2024 (+9.8%), 7.66 million in FY2023 (+40.4%), 5.46 million in FY2022 (+8.1%) and 5.05 million in FY2021 (+2.5%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2012.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 2.2% (Q1 2024) and 234.7% (Q2 2026) over the last five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Karyopharm Therapeutics | 35.30 Mn | -191.12 Mn | 32.35 Mn | 28.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.94 Mn |
| Dec 31, 2025 | 10.94 Mn |
| Sep 30, 2025 | 8.70 Mn |
| Jun 30, 2025 | 8.65 Mn |
| Mar 31, 2025 | 8.57 Mn |
| Dec 31, 2024 | 8.41 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Mar 31, 2024 | 7.76 Mn |
| Dec 31, 2023 | 7.66 Mn |
| Sep 30, 2023 | 7.64 Mn |
| Jun 30, 2023 | 7.62 Mn |
| Mar 31, 2023 | 7.60 Mn |
| Dec 31, 2022 | 5.46 Mn |
| Sep 30, 2022 | 5.40 Mn |
| Jun 30, 2022 | 5.32 Mn |
| Mar 31, 2022 | 5.29 Mn |
| Dec 31, 2021 | 5.05 Mn |
| Sep 30, 2021 | 5.03 Mn |
| Jun 30, 2021 | 5.02 Mn |
API Access
Karyopharm Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();